91. Budd-Chiari syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 5 - (DrugBank : 4) / Drug target genes : 4 - Drug target pathways : 14
Drugs and their primary sponsors and trial info
Dabigatran
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
2012 - JPRN-UMIN000015319 Japan;
Gold
Affiliated Hospital of Xuzhou Medical University
2018 - ChiCTR1800017925 -
Rivaroxaban
The First Affiliated Hospital of Zhengzhou University
2022 - ChiCTR2100046725 China;
University of Insubria
2020 Phase 4 EUCTR2014-005162-29-NL Canada;France;Germany;Italy;Netherlands;
Warfarin
The First Affiliated Hospital of Zhengzhou University
2022 - ChiCTR2100046725 China;
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
2012 - JPRN-UMIN000015319 Japan;
Gold
Affiliated Hospital of Xuzhou Medical University
2018 - ChiCTR1800017925 -
Rivaroxaban
The First Affiliated Hospital of Zhengzhou University
2022 - ChiCTR2100046725 China;
University of Insubria
2020 Phase 4 EUCTR2014-005162-29-NL Canada;France;Germany;Italy;Netherlands;
Warfarin
The First Affiliated Hospital of Zhengzhou University
2022 - ChiCTR2100046725 China;